Mettler-Toledo International, Inc. MTD
1,511.64
(7.51)
(0.49%)
as of 25 Sep
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Indexes
indicate stock being part of an index
Mettler-Toledo International, Inc. (MTD) P/S ratio
As of 25 September 2026, Mettler-Toledo International, Inc. (MTD) trades at a P/S ratio of 7.4×. Over the past ten years it has ranged from 3.2× (September 2015) to 10.8× (December 2021); the current reading is higher than 71% of that period. That is above the Diagnostics & Research industry median of 4.9× and above the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 7.1× | 6.42% |
| FY2024 | 6.7× | (4.23%) |
| FY2023 | 7.0× | (16.52%) |
| FY2022 | 8.4× | (20.55%) |
| FY2021 | 10.6× | 19.68% |
| FY2020 | 8.8× | 36.20% |
| FY2019 | 6.5× | 33.34% |
| FY2018 | 4.9× | (17.77%) |
| FY2017 | 5.9× | 32.31% |
| FY2016 | 4.5× | 13.94% |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 6.2× | (0.60%) |
| Mar 2026 | 6.3× | (12.34%) |
| Dec 2025 | 7.1× | 11.72% |
| Sep 2025 | 6.4× | 1.64% |
| 42 more quarters | Free account |
Against its own ten years
Low 3.2×
High 10.8×
Ten-year median
6.4×
Current reading's percentile
71
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| LH Labcorp Holdings Inc. compare | 1.8× |
| DGX Quest Diagnostics Incorporated compare | 2.3× |
| IQV IQVIA Holdings Inc. compare | 2.6× |
| A Agilent Technologies, Inc. compare | 6.6× |
| MTD Mettler-Toledo International, Inc. | 7.4× |
| IDXX IDEXX Laboratories, Inc. compare | 9.0× |
| ILMN Illumina, Inc. compare | 9.2× |
| WAT Waters Corporation compare | 9.2× |
| GH Guardant Health, Inc. compare | 19.9× |
| Diagnostics & Research industry median | 4.9× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on MTD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement